HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prostagut forte treatment of patients with prostatic adenoma with comorbid chronic prostatitis].

Abstract
The study consisting of four visits included 69 patients with prostatic adenoma and concomitant chronic prostatitis. The patients received either monotherapy with an alpha adrenoblocker or combined treatment including phytodrug prostagut forte. The results of the study showed that the above combined treatment produces more pronounced and persistent improvement of urodynamic indices, leads to reduction of leukocyte count in the urine and prostatic secretion, upgrades quality of life. The absence of side effects allows recommendation of prostagut forte for treatment of presenile and senile patients with prostatic adenoma and associated pathology.
AuthorsV P Avdoshin, S A Pul'bere
JournalUrologiia (Moscow, Russia : 1999) (Urologiia) 2012 Mar-Apr Issue 2 Pg. 44, 46-7 ISSN: 1728-2985 [Print] Russia (Federation)
PMID22876633 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Plant Preparations
  • Prostagut forte
Topics
  • Adult
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Plant Preparations (administration & dosage, adverse effects)
  • Prostatic Hyperplasia (complications, drug therapy, physiopathology, urine)
  • Prostatitis (complications, drug therapy, physiopathology, urine)
  • Quality of Life
  • Urodynamics (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: